Prognostic Power of the VEXUS Score in Septic Shock: Effectiveness in Mortality Prediction
1 other identifier
observational
100
0 countries
N/A
Brief Summary
This study aims to evaluate the prognostic power of the VEXUS Score in predicting mortality among patients with septic shock in intensive care units.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2025
CompletedFirst Posted
Study publicly available on registry
August 15, 2025
CompletedStudy Start
First participant enrolled
March 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
August 15, 2025
August 1, 2025
3 months
August 8, 2025
August 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
28-day intensive care unit mortality in relation to VEXUS score
Investigation of the relationship between VEXUS Score and 28-day mortality in patients diagnosed with septic shock in the intensive care unit.
Up to 28 days following intensive care unit admission.
Secondary Outcomes (4)
Need for mechanical ventilation in relation to VEXUS score
Within the first 72 hours of intensive care unit admission.
Duration of mechanical ventilation in relation to VEXUS score.
From intensive care unit patients admission until extubation, up to 28 days.
Length of intensive care unit stay in relation to VEXUS score
From intensive care unit admission until intensive care unit discharge, up to 28 days.
Vasopressor dose and duration in relation to VEXUS score.
First 72 hours after intensive care unit admission
Study Arms (1)
Septic shock cohort
All patients diagnosed with septic shock in the ıntensive care unit will undergo serial ultrasonographic evaluations to calculate the VEXUS Score at 0-4 hours, 12-24 hours, and 72 hours. These scores will be analyzed in relation to 28-day mortality. No treatment decisions will be made based on the VEXUS results.
Interventions
Ultrasound assessments will be performed by an experienced anesthesiologist at three time points (0-4 hours, 12-24 hours, and 72 hours)to determine the degree of venous congestion using the VEXUS Score. No treatment changes will be made based on the VEXUS findings. The scores will solely be used for prognostic correlation with mortality outcomes.
Eligibility Criteria
Adult patients admitted to the intensive care unit with a diagnosis of septic shock according to Sepsis-3 criteria. Patients will be enrolled consecutively from the intensive care unit of a tertiary care university hospital. Informed consent will be obtained from all patients or their legal representatives.
You may qualify if:
- Age\>18
- Patients monitored for septic shock in intensive care unit
- Signed informed consent
You may not qualify if:
- Age \<18
- Severe obesity precluding adequate ultrasonographic imaging.
- Patients in whom venous structures cannot be clearly assessed via ultrasonography due to anatomical or technical reasons (e.g., adhesions following abdominal surgery).
- Patients receiving dialysis due to chronic kidney disease or initiating dialysis for acute kidney failure.
- Chronic heart failure.
- Patients with advanced valvular insufficiency or advanced pulmonary hypertension.
- Patients with portal hypertension or advanced-stage liver cirrhosis.
- Presence of acute or chronic thrombosis in the inferior vena cava or other venous structures within the scoring area.
- Refusal to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Nilgun Kavrut Ozturk, Professor
University of Health Sciences Antalya Training and Research hospital
Central Study Contacts
Havva Dikici, Medical Doctor
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 8, 2025
First Posted
August 15, 2025
Study Start
March 30, 2026
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
August 15, 2025
Record last verified: 2025-08